Intellipharmaceutics International Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Isa Odidi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 26.5yrs |
| CEO ownership | n/a |
| Management average tenure | 26.5yrs |
| Board average tenure | 18.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2023 | n/a | n/a | -US$3m |
| May 31 2023 | n/a | n/a | -US$2m |
| Feb 28 2023 | n/a | n/a | -US$2m |
| Nov 30 2022 | US$348k | US$335k | -US$3m |
| Aug 31 2022 | n/a | n/a | -US$4m |
| May 31 2022 | n/a | n/a | -US$5m |
| Feb 28 2022 | n/a | n/a | -US$5m |
| Nov 30 2021 | US$375k | US$361k | -US$5m |
| Aug 31 2021 | n/a | n/a | -US$5m |
| May 31 2021 | n/a | n/a | -US$3m |
| Feb 28 2021 | n/a | n/a | -US$3m |
| Nov 30 2020 | US$363k | US$349k | -US$3m |
| Aug 31 2020 | n/a | n/a | -US$3m |
| May 31 2020 | n/a | n/a | -US$6m |
| Feb 29 2020 | n/a | n/a | -US$7m |
| Nov 30 2019 | US$560k | US$340k | -US$8m |
| Aug 31 2019 | n/a | n/a | -US$11m |
| May 31 2019 | n/a | n/a | -US$13m |
| Feb 28 2019 | n/a | n/a | -US$14m |
| Nov 30 2018 | US$1m | US$350k | -US$14m |
| Aug 31 2018 | n/a | n/a | -US$12m |
| May 31 2018 | n/a | n/a | -US$11m |
| Feb 28 2018 | n/a | n/a | -US$10m |
| Nov 30 2017 | US$2m | US$343k | -US$9m |
Compensation vs Market: Insufficient data to establish whether Isa's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Isa's compensation has been consistent with company performance over the past year.
CEO
Isa Odidi (66 yo)
26.5yrs
Tenure
US$347,941
Compensation
Dr. Isa Odidi, Ph D., MBA has been the Chief Executive Officer and Co-Chief Scientific Officer at IntelliPharmaCeutics International Inc. since September 1, 2004. In 1998, Dr. Odidi co-founded Intellipharm...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 26.5yrs | US$347.94k | no data | |
| President | 26.5yrs | US$347.94k | no data | |
| Vice-President of Chemistry & Analytical Services | 19.5yrs | US$119.93k | 0.0082% CA$ 217.4 | |
| Controller | no data | no data | no data |
26.5yrs
Average Tenure
66yo
Average Age
Experienced Management: IPCI.H's management team is seasoned and experienced (26.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 19.8yrs | US$347.94k | no data | |
| President | 19.8yrs | US$347.94k | no data | |
| Independent Director | 18.3yrs | US$34.94k | 0.0023% CA$ 60.1 | |
| Independent Non-Executive Director | 6.2yrs | US$31.22k | no data | |
| Independent Non-Executive Director | 5.5yrs | US$31.22k | no data |
18.3yrs
Average Tenure
65yo
Average Age
Experienced Board: IPCI.H's board of directors are seasoned and experienced ( 18.3 years average tenure).